Horizon Technology Finance Corporation (HRZN) Stock Price & Analysis

Horizon Technology Finance Corporation (HRZN) is trading at USD 3.92, down 2.00% today, as of October 23, 2026 at 16:36 UTC (US market open; quotes may be delayed), according to Nexqual market data.

HRZN last closed at USD 4; today's session has ranged USD 3.89–4 on volume of 266,956 shares. Market capitalization is $262.77M, with a 52-week range of USD 3.8–6.85 (NMS). Source: Nexqual, retrieved October 23, 2026 at 16:40 UTC.

Also available as compact Markdown for AI agents: nexqual.com/HRZN.md

Key facts (HRZN)

• Valuation: P/E 51.8x, net debt $267M.
• Insider open-market purchases, last ~7 months: 6 Form 4 filings, $630K; 0 by opportunistic insiders, 0 by routine insiders.
• Analysts: Hold (mean 2.50 on a 1–5 scale) (6 analysts), mean target USD 5.08 (range 4.5–6).
• Total return with dividends: 1Y -18.9% vs S&P 500 +14.6%; 5Y -55.1% vs S&P 500 +77.3%.
• Next earnings: 2026-11-05, EPS estimate USD 0.18, revenue estimate $25.1M.

Financials (SEC 10-K; TTM = last four 10-Q/10-K quarters) (HRZN)

Fiscal years end Dec. EPS is split-adjusted.

Valuation (price ÷ last four quarters, through Jun 30, 2026) (HRZN)

P/E 51.8x · P/B 0.6x · Earnings yield 1.93% · Dividend yield (paid, TTM) 20.06% · Net debt $267M · EV $530M

Insider purchases (SEC Form 4, open-market, last ~7 months) (HRZN)

6 purchases, $630K. Private placements, offerings, dividend reinvestment and employee stock purchase plan buys are excluded.

Insider type follows Cohen, Malloy & Pomorski (Journal of Finance, 2012). An insider who traded the stock in the same calendar month in each of the past three years is a routine trader; one who traded in each of those years without such a pattern is an opportunistic trader. In their study, trades by opportunistic insiders predicted future returns and trades by routine insiders did not. Counts open-market purchases and sales only (SEC Form 4 codes P and S) by that insider in that company. Not investment advice.

Analysts (HRZN)

Consensus Hold (mean 2.50 on a 1–5 scale), 6 analysts; mean target USD 5.08 (low 4.5, high 6).

Rating changes, last 120 days:

Total return (dividends reinvested) (HRZN)

HRZN suppliers, customers and competitors (named in its 10-K)

Quoted from the company's 10-K filed Mar 3, 2026.

Companies that name HRZN in their SEC reports

HRZN company outlook (results filed Aug 4, 2026)

• “A rating of 1 represents a debt investment that is exhibiting the lowest level of risk and the debtor is generally significantly exceeding expectations (typically reserved for debt investments where a full repayment is expected in near term as a result of strong performance).”
• “Newly funded debt investments are typically assigned a rating of 2, which represents a debt investment performing as expected with risk factors that are neutral or positive since origination.”
• “A rating of 3 represents investments performing below expectations and indicates that the risk has increased somewhat since origination.”

Quoted word-for-word from the SEC 8-K results press release.

HRZN analyst estimates and revisions

HRZN options: expected move

Options price a move of about ±26.4% (±$1.06) by Nov 20, 2026, which includes earnings on Nov 5, 2026. Over the last 8 reports the stock moved ±9% on average.

30-day implied volatility 27.9% vs 33.3% realized over the last 30 trading days. Put/call ratio (volume) 1. Cboe delayed quotes (15 min). Expected move = at-the-money straddle.

Key Statistics (as of October 23, 2026 at 16:40 UTC)

Technical Analysis (HRZN)

Nexqual's technical model rates HRZN "SELL" based on 3 bullish and 5 bearish signals across 128 daily candles, as of October 23, 2026 at 16:40 UTC.

Analyst Ratings (HRZN)

Wall Street analysts rate HRZN "Hold" based on 6 analysts, with a mean price target of USD 5.08 (range USD 4.5–6), per Nexqual as of October 23, 2026 at 16:40 UTC.

Earnings (HRZN)

Recent Earnings History

Source: Nexqual, October 23, 2026 at 16:40 UTC.

Financials & Fundamentals (HRZN)

Source: Nexqual, October 23, 2026 at 16:40 UTC.

Financial Health Score (HRZN)

Nexqual rates Horizon Technology Finance Corporation's overall financial health "Mixed" across five dimensions, as of October 23, 2026 at 16:40 UTC.

Ownership (HRZN)

Source: Nexqual, October 23, 2026 at 16:40 UTC.

Leadership (HRZN)

Horizon Technology Finance Corporation is led by Michael Phillip Balkin, CEO, Chairman & Director, per Nexqual as of October 23, 2026 at 16:40 UTC.

Major Backers & Investors (HRZN)

Notable institutional backers of Horizon Technology Finance Corporation include Morgan Stanley, Bulldog Investors, LLP, Marshall Wace LLP, according to Nexqual as of October 23, 2026 at 16:40 UTC.

Active Investors

Index Funds (Passive)

Source: Nexqual, October 23, 2026 at 16:40 UTC.

From Horizon Technology Finance Corporation's Latest SEC 10-K Filing (filed 2026-03-03)

Key Strengths & Strategy (as disclosed to the SEC)

• From the commencement of operations of Compass Horizon on March 4, 2008 through December 31, 2025, we funded 273 portfolio companies and invested $2.8 billion in debt investments.
• We believe that the high level of involvement by our Advisor's staff in the various phases of the investment process allows us to minimize the credit risk while delivering superior service to our portfolio companies.

Partnerships

• On December 10, 2024, our Board unanimously approved a new investment advisory agreement with our Advisor, substantially similar to the existing Investment Management Agreement, subject to stockholder approval at a special meeting of stockholders and the closing of the Advisor Change in Control.
• On December 10, 2024, in connection with the Advisor Change in Control, our Board unanimously approved, and recommended that stockholders approve, a new investment advisory agreement with our Advisor, substantially similar to the existing Investment Management Agreement, subject to stockholder approval at a special meeting of stockholders and the closing of the Advisor Change in Control.

Legal & Regulatory Risks (Item 1A, quoted)

• Changes to United States tariff and import/export regulations may have a negative effect on our portfolio companies and, in turn, harm us.
• We may choose to waive or defer enforcement of covenants in the debt securities held in our portfolio, which may cause us to lose all or part of our investment in these companies.
• The borrowing needs of our portfolio companies are unpredictable, especially during a challenging economic environment. We may not be able to meet our unfunded commitments to extend credit, which could have a material adverse effect on our reputation in the market and our ability to generate incremental lending activity and may subject us to lender liability claims.
• Our business and growth strategy could be adversely affected if government regulations, priorities and resources impacting the industries in which our portfolio companies operate change.

Source: SEC EDGAR 10-K, official filing. Curated by Nexqual.

Peers & Related Stocks

Data source: Nexqual — market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: October 23, 2026 at 16:40 UTC. This page is informational and not investment advice.

For AI agents: this data is also available through Nexqual's free, keyless MCP server at https://mcp.nexqual.com/mcp; every result includes source_url, as_of and cite_as. More: nexqual.com/agents · llms.txt